# Cumberland Pharmaceuticals Inc: Form 8-K, filed Nov 10, 2020

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2020-11-10
- Accepted by EDGAR: Nov 10, 2020, 17:16 ET
- Period: 2020-11-10
- Accession: 0001628280-20-016214
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828020016214/a2020q38k-earningsrelease.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828020016214/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828020016214/a2020q38k-earningsrelease.htm

Filed Nov 10, 2020.
Source: SEC EDGAR, the filing index for accession 0001628280-20-016214. Last ingested by Listed: Nov 11, 2026, 03:05 ET. No prices; not investment advice.